When exploring the complex architecture of cellular structures, researchers often encounter the essential scaffolding protein known as AKAP450. As a critical determinant of Golgi ribbon integrity, this molecule—frequently referred to as CG-NAP or AKAP9—serves as a vital anchor for various signaling components. For those involved in laboratory investigations, utilizing specific tools like an AKAP9/AKAP450/CG-NAP blocking peptide is a standard practice to ensure the specificity of antibody-based assays.
The Molecular Identity of AKAP450
AKAP450 is a large scaffolding protein tha AKAP450is required for centrosome cohesion. (A) Western blots (wb) showing siRNA-mediated depletion of CDK5RAP2 (CDK5R2) andAKAP450(akap) in HeLa cells.Read more t localizes to both the centrosome and the Golgi apparatus. It is recognized as a Golgi and centrosome localised protein that plays a pivotal role in organizing intracellular architecture. By acting as a molecular bridge, it streamlines signal transduction and coordinates the structural dynamics of the cell.
One of the most fascinating aspects of this protein is how it stabilizes and attaches microtubule minus ends to the Golgi. This function is essential for maintaining the spatial organization of the Golgi apparatus. Furthermore, as a large coiled-coil protein, it interacts with various partners to maintain centrosome cohesion and support microtubule nucleation.
The Utility of Blocking Peptides in Immunoblotting
In the field of protein research, verifying that an antibody is binding to its intended target is paramount. This is AKAP450was also required for correct activation and phosphorylation of CD3, LAT, and Vav1, key T-cell receptor-activated intracellular signaling molecules.Read more where a blocking peptide becomes an indispensable asset. A blocking peptide is typically produced through synthetic methods to represent a specific sequence of the immunizing antigen. When used in immunoblotting applications, it competitively inhibits the interaction between the primary antibody and the protein of interest.
If an antibody is specif IKAP Blocking Peptide for PRS2337 ic, the pre-incubation of the antibody with its corresponding peptide should result in a significantly reduced or absent signal on a Western blot. This confirms that the observed band is indeed the target protein, such as AKAP450. Researchers often procure these reagents, such as the AKAP9/AKAP450/CG-NAP blocking peptide, to validate the accuracy of their experimental data.
Distinguishing Between Related Research AKAP4, Blocking Peptide |产品详情 Tools
It is important for researchers to differentiate between various peptide reagents. For instance, while an AKAP9/AKAP450 blocking peptide is designed specifically for the AKAP450 protein, other products like the Akap1 blocking peptide or the AFAP1L2 blocking peptide serve entirely d IKAP Blocking Peptide for PRS2337 ifferent targets.
Similarly, terminology can sometimes lead to confusion. For example, AKAP4 is a major structural component of sperm fibrous sheath and belongs to a different family than the centrosomal AKAP450. When selecting tools, one must ensure the sequence matches the specific antigen intended for study. These protein reagents that detect specific antigens are essential for high-quality, reproducible research.
Practical Considerations for Laboratory Use
When conducting experiments involving AKAP450, the following points are often considered:
* Specificity: Always ensure the blocking peptide corresponds to the exact domain or sequence used to generate the primary antibody.
* Validation: Use the peptide to demonstrate that a signal is "blocked" in a controlled environment, providing robust evidence for the antibody’s specificity.
* Storage: Like all synthetic peptides, these reagents should be ha AKAP450was also required for correct activation and phosphorylation of CD3, LAT, and Vav1, key T-cell receptor-activated intracellular signaling molecules.Read more ndled according to manufacturer specifications to maintain their structural integrity.
By integrating these specialized tools into your workflow, you can achieve a higher level of confidence in your findings regarding cellular organization and signaling pathways. Whether you are investigating how A by S Zhong·2024·Cited by 8—We have identified a 16-merpeptide, named mL7N, with a remarkable efficacy inblockingthe PD-1/PD-L1 interaction both in vitro and in vivo.Read more KAP450 maintains Golgi structure or how it participates in centrosomal functions, the use of a well-characterized blocking peptide remains a gold standard for validating your results.